Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia [Letter]

Allan, J. M., Sunter, N. J., Bailey, J. R., Pettitt, A. R., Harris, R. J., Pepper, Christopher John, Fegan, Christopher Daniel ORCID: https://orcid.org/0000-0001-9685-0621, Hall, A. G., Deignan, L, Bacon, C. M., Pointon, J. C., Houlston, R. S., Broderick, P, Mainou-Fowler, T, Jackson, G. H., Summerfield, G, Evans, P. A., Strefford, J. C., Parker, A, Oscier, D, Pratt, G and Allsup, D. J. 2010. Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia [Letter]. Leukemia 24 (4) , pp. 877-881. 10.1038/leu.2009.298

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher:	Nature Publishing Group
ISSN:	0887-6924
Last Modified:	04 Jun 2017 03:47
URI:	https://orca.cardiff.ac.uk/id/eprint/26688

Citation Data

Cited 17 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item